Symposium 2022 Posters An in vitro/in vivo platform to test the anti-tumor activity of tyrosine kinase inhibitors in medullary thyroid cancer Read More » January 24, 2023 No Comments
Symposium 2022 Posters Monitoring the treatment of AR42J tumor-bearing mice with 225Ac-Crown-TATE Read More » January 24, 2023 No Comments
Symposium 2022 Posters PAK4/NAMPT inhibitor KPT-9274 synergizes with Sunitinib in Pancreatic Neuroendocrine Tumor Cellular Models Read More » January 24, 2023 No Comments
Symposium 2022 Posters Single cell RNA-seq analysis of neuroendocrine tumors Read More » January 24, 2023 No Comments
Symposium 2022 Posters Proximity to Healthcare Providers, Bankruptcy, and Relationship Status within Neuroendocrine Cancer Patients Read More » January 24, 2023 No Comments
Symposium 2022 Posters Economic disparity lowers neuroendocrine cancer diagnosis Read More » January 24, 2023 No Comments
Symposium 2022 Posters Investigating the Role of Pseudohypoxia-related Metabolites in GEP-NET Read More » January 24, 2023 No Comments
Symposium 2022 Posters Neuron-specific enolaseâ€� revisited: a new drug target in SDH-deficient paraganglioma? Read More » January 24, 2023 No Comments
Symposium 2022 Posters Effect of Epigenetic Treatment on SST2 Expression in Neuroendocrine Tumor Patients Read More » January 24, 2023 No Comments
Symposium 2022 Posters A novel anti-SSTR bispecific T-cell engager (BiTE®)-like molecule for the treatment of neuroendocrine tumors Read More » January 24, 2023 No Comments
